Dr. Mike Mallin is a former ER doctor who has also taught tens of thousands of physicians and the co-creator of the Ultrasound Podcast, which is an ultrasound education tool for physicians, and the Ultrasound Leadership Academy, a non-profit education company that has taught all over the globe.

Dr. Mallin is also the co-founder of Wild Health, a company that uses advanced machine learning and combines it with DNA analysis, biometrics, microbiome testing, and phenotypic data to give you a personalized blueprint to optimize your health and lifespan. Dr. Mallin and his team are upending a broken medical system and they’re creating an incredible, individualized, and better approach to healthcare.

In this episode, Dr. Mallin discusses the differences between genetics and epigenetics, how often DNA testing should be done, what precision medicine is and how it differs from standard medicine, the issues with relying on traditional blood work alone, and so much more.

Here is the episode breakdown:

00:00 Introduction to the Keto Answers podcast
00:29 Introduction to this episode’s guest, Dr. Mike Mallin
02:55 Dr. Mallin’s background and what brought him to the precision medicine space
08:28 Should you test your DNA often and after implementing intervention strategies?, What’s epigenetics?, and How does epigenetics differ from genetics?
12:15 If you have genes that say you can’t metabolize certain nutrients, does it mean it will be that way forever?
18:45 Is a weight loss plateau connected to your epigenetics?
26:57 How Dr. Mallin uses his traditional medical background while practicing precision medicine
41:34 Do you test blood work or genetics first to determine the best plan of action?
45:26 Are there genes that can tell you more about your behavior?
48:35 What the data shows on the long-term success rate of a precision medicine approach

Resources mentioned in this episode:

Dr. Mike Mallin’s website, Wild Health
Dr. Mallin’s Instagram and Twitter
Dr. Mallin’s Wild Health podcast

FPG 169 – Professionelle Preisverhandlung im B2B – Interview mit Tim Taxis – Teil 1